Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Covetrus, Inc.    CVET

COVETRUS, INC.

(CVET)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Covetrus : Announces Third Quarter 2020 Earnings Release Date and Conference Call Information

10/27/2020 | 07:31am EST

PORTLAND, Maine, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, announced today that it will release third quarter 2020 results after the market close on Tuesday, November 10, 2020. Following the release, the company will hold a conference call at 4:30 PM ET, during which Covetrus president and chief executive officer, Benjamin Wolin, and executive vice president and chief financial officer, Matthew Foulston, will review the results.

To access the live webcast of the conference call, individuals can visit the Investor Relations page of the Covetrus website: https://ir.covetrus.com/investors/events-and-presentations. An archived edition of the earnings conference call will also be posted on the Covetrus website later that day and will remain available to interested parties via the same link for one year.

The conference call can also be accessed by dialing 866-789-2492 for U.S./Canada participants, or 409-937-8901 for international participants, and referencing confirmation code 4668669. A replay of the conference call will be available for two weeks through November 24, 2020 by dialing 855-859-2056 or 404-537-3406. The replay confirmation code is 4668669.

About Covetrus
Covetrus is a global animal-health technology and services company dedicated to empowering veterinary practice partners to drive improved health and financial outcomes. We’re bringing together products, services, and technology into a single platform that connects our customers to the solutions and insights they need to work best. Our passion for the well-being of animals and those who care for them drives us to advance the world of veterinary medicine. Covetrus is headquartered in Portland, Maine, with more than 5,500 employees, serving over 100,000 customers around the globe. For more information about Covetrus visit https://www.covetrus.com/.

Forward-Looking Statements
This press release contains certain statements that are forward-looking within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and that involve risks and uncertainties, including statements about our plans, objectives, expectations, and intentions. Such statements are subject to numerous risks and uncertainties. Factors that could adversely affect our business and prospects are set forth in our public filings with the Securities and Exchange Commission. Our forward-looking statements are based on current beliefs and expectations of our management team and, except as required by law, we undertake no obligations to make any revisions to the forward-looking statements contained in this release or to update them to reflect events or circumstances occurring after the date of this release, whether as a result of new information, future developments or otherwise. Investors are cautioned not to place undue reliance on these forward-looking statements.


CONTACTS
Nicholas Jansen, Investor Relations
nicholas.jansen@covetrus.com
(207) 550-8106

Kiní Schoop, Public Relations
kini.schoop@covetrus.com
(207) 550-8018

4200839_Covetrus_Logo_cmyk-TM.jpg

Source: Covetrus

2020 GlobeNewswire, Inc., source Press Releases

All news about COVETRUS, INC.
01/13COVETRUS, INC. : Results of Operations and Financial Condition, Regulation FD Di..
AQ
01/06COVETRUS : to Present at the 39th Annual J.P. Morgan Healthcare Conference
BU
01/04COVETRUS : Presidio Announces Appointment of Christine Komola as New CFO
AQ
2020COVETRUS : Completes Separation from Former Parent Company
BU
2020COVETRUS, INC. : Submission of Matters to a Vote of Security Holders, Regulation..
AQ
2020Credit Suisse Adjusts Price Target for Covetrus to $20 From $17, Maintains Ne..
MT
2020COVETRUS : Management's Discussion and Analysis of Financial Condition and Resul..
AQ
2020Covetrus Narrows Q3 Loss Amid Higher Revenue, Ups Full Year Earnings Guidance
MT
2020COVETRUS : 3Q Earnings Snapshot
AQ
2020COVETRUS, INC. : Results of Operations and Financial Condition, Financial Statem..
AQ
More news
Financials (USD)
Sales 2020 4 273 M - -
Net income 2020 -23,0 M - -
Net Debt 2020 674 M - -
P/E ratio 2020 -158x
Yield 2020 -
Capitalization 4 825 M 4 825 M -
EV / Sales 2020 1,29x
EV / Sales 2021 1,20x
Nbr of Employees 5 300
Free-Float 72,5%
Chart COVETRUS, INC.
Duration : Period :
Covetrus, Inc. Technical Analysis Chart | CVET | US22304C1009 | MarketScreener
Technical analysis trends COVETRUS, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 30,00 $
Last Close Price 37,84 $
Spread / Highest target -7,51%
Spread / Average Target -20,7%
Spread / Lowest Target -36,6%
EPS Revisions
Managers and Directors
NameTitle
Benjamin C. Wolin President, Chief Executive Officer & Director
Philip A. Laskaway Chairman
Matthew J. Foulston Chief Financial Officer
Georgina Wraight President-Global Technology Solutions & EVP
Steve Palmucci Global Chief Information Officer
Sector and Competitors
1st jan.Capitalization (M$)
COVETRUS, INC.31.66%4 825
ABBOTT LABORATORIES4.78%196 561
MEDTRONIC PLC-0.20%157 350
BECTON, DICKINSON AND COMPANY4.00%75 691
HOYA CORPORATION-3.92%49 122
ALIGN TECHNOLOGY, INC.0.95%42 537